A Phase 1 Exploratory Study to Evaluate the Pharmacokinetics of Selected Oral Formulations of MMV390048 Administered in the Fasted State to Healthy Volunteers
Latest Information Update: 16 Jan 2020
At a glance
- Drugs MMV 390048 (Primary)
- Indications Malaria
- Focus Pharmacokinetics
- 13 Jan 2020 Results assessing safety, pharmacokinetic profile and antimalarial activity of MMV39004 to reach clinical development from trials (NCT02230579, NCT02281344 and NCT02554799) published in the Antimicrobial Agents and Chemotherapy
- 18 Apr 2016 Status changed from not yet recruiting to completed.
- 23 Sep 2015 New trial record